PDL BioPharma (FRA:PDL) Net Income Including Noncontrolling Interests : €-139.32 Mil (TTM As of Jun. 2020)

View and export this data going back to 2006. Start your Free Trial

What is PDL BioPharma Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

PDL BioPharma's Net Income Including Noncontrolling Interests for the three months ended in Jun. 2020 was €-44.69 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2020 was €-139.32 Mil.

PDL BioPharma Net Income Including Noncontrolling Interests Historical Data

The historical data trend for PDL BioPharma's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PDL BioPharma Net Income Including Noncontrolling Interests Chart

PDL BioPharma Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Net Income Including Noncontrolling Interests

Get a 7-Day Free Trial

305.51

60.35

93.54

-60.53

-63.62

PDL BioPharma Quarterly Data
	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial															-4.00	-16.31	-49.35	-28.97	-44.69

PDL BioPharma Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €-139.32 Mil.

PDL BioPharma Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of PDL BioPharma's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

PDL BioPharma (FRA:PDL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PDL BioPharma Inc (FRA:PDL) » Definitions » Net Income Including Noncontrolling Interests

Comparable Companies

Traded in Other Exchanges

N/A

Address

932 Southwood Boulevard, Incline Villiage, NV, USA, 89451

Website

http://www.pdl.com

PDL BioPharma Inc acquires and manages a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries. The operating segments of the company are Medical Devices, Strategic Positions, Pharmaceutical and Income Generating Assets, of which key revenue is derived from the Pharmaceutical segment. The Pharmaceutical segment consists of revenue derived from branded prescription medicine products sold under the name Tekturna and Tekturna HCT in the U.S, and Rasilez and Rasilez HCT in the rest of the world (collectively, the Noden Products). Geographically, the company operates in Europe, North America, Asia and Other countries, of which prime revenue is generated from Asia and North America.

PDL BioPharma (FRA:PDL) Headlines

No Headlines